1-10 of 10
S. Lonial
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Report from a Multicenter Trial of Perifosine (KRX-0401) + Bortezomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma Previously Treated with Bortezomib.

Paul Richardson, A. Jakubowiak, J. Wolf, J. Allerton, J. Zonder, S. Lonial, A. Krishnan, J. Densmore, I. Ghobrial, K. Colson, T. Kendall, C. Leister, B. Martineau, T. Hideshima, T. Facon, P. Sportelli, L. Gardner, R. Birch, I.C. Henderson, K. Anderson
Journal: Blood
Blood (2007) 110 (11): 1170.
https://doi.org/10.1182/blood.V110.11.1170.1170
Published: 2007
Journal Articles

Multi-Center Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Promising Activity as Combination Therapy with Manageable Toxicity.

Paul Richardson, S. Lonial, A. Jakubowiak, A. Krishnan, J. Wolf, J. Densmore, S. Singhal, I. Ghobrial, J. Stephenson, J. Mehta, K. Colson, D. Francis, T. Kendall, N. Obadike, K. Sullivan, J. Martin, T. Hideshima, L. Lai, P. Sportelli, L. Gardner, R. Birch, I.C. Henderson, K. Anderson
Journal: Blood
Blood (2007) 110 (11): 1164.
https://doi.org/10.1182/blood.V110.11.1164.1164
Published: 2007
Journal Articles

Phase II Trial of SCIO-469 as Monotherapy (M) or in Combination with Bortezomib (MB) in Relapsed Refractory Multiple Myeloma (MM).

David S. Siegel, MD, PhD, A. Krishnan, MD, S. Lonial, MD, G. Chatta, MD, M. Alsina, MD, S. Jagannath, MD, P. Richardson, MD, R.J. Hohl, MD, J.A. Lust, MD, W. Bensinger, MD, G. Carrum, MD, J. Moreb, MD, A. Simic, MD, B. Barlogie, MD.PhD, R.T. Maziarz, MD, K.C. Anderson, MD, J. Lin, PhD, A. Lowe, MD, S. Vetticaden, MD, PhD, J. Zhu, MD
Journal: Blood
Blood (2006) 108 (11): 3580.
https://doi.org/10.1182/blood.V108.11.3580.3580
Published: 2006
Journal Articles

A Multicenter Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (Dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM).

Paul Richardson, S. Lonial, A. Jakubowiak, J. Wolf, A. Krishnan, J. Densmore, S. Singhal, I. Ghobrial, L. Schwartzberg, K. Colson, J. Harris, T. Kendall, B. Martineau, N. Obadike, K. Sullivan, S. Pearson, T. Hideshima, L. Lai, P. Sportelli, L. Gardner, R. Birch, I.C. Henderson, K.C. Anderson
Journal: Blood
Blood (2006) 108 (11): 3582.
https://doi.org/10.1182/blood.V108.11.3582.3582
Published: 2006
Journal Articles

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.

J.F. San Miguel, P. Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 366.
https://doi.org/10.1182/blood.V106.11.366.366
Published: 2005
Journal Articles

Phase 1 Clinical Trial of KOS-953 + Bortezomib (BZ) in Relapsed Refractory Multiple Myeloma (MM).

Asher Alban Chanan-Khan, MD, P. G. Richardson, MD, M. Alsina, MD, M. Carroll, MD, S. Lonial, MD, A. Krishnan, MD, M. Albitar, MD, Y. Zhou, MD, C. Mitsiades, MD, G. Cropp, MS, A. L. Hannah, MD, K. C. Anderson, MD
Journal: Blood
Blood (2005) 106 (11): 362.
https://doi.org/10.1182/blood.V106.11.362.362
Published: 2005
Journal Articles

Bortezomib Continues Demonstrates Superior Efficacy Compared with High-Dose Dexamethasone in Relapsed Multiple Myeloma: Updated Results of the APEX Trail.

Paul Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. San Miguel, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 2547.
https://doi.org/10.1182/blood.V106.11.2547.2547
Published: 2005
Journal Articles

A Multicenter Phase II Trial of Bortezomib in Patients with Previously Untreated Multiple Myeloma: Efficacy with Manageable Toxicity in Patients with Unexpectedly High Rates of Baseline Peripheral Neuropathy.

Paul Richardson, A. Chanan-Khan, R. Schlossman, N. Munshi, P. Wen, H. Briemberg, D. Kuter, A. Oaklander, S. Lonial, H. Hassoun, D. Doss, L. Lunde, S. Hayes, M. McKenney, K. Hande, L. Lai, A. Freeman, K. Dinand, C. McAlister, D. Warren, D. Collins, D. Esseltine, A. Amato, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 2548.
https://doi.org/10.1182/blood.V106.11.2548.2548
Published: 2005
Journal Articles

Safety and Efficacy of Bortezomib in Multiple Myeloma Patients with Renal Failure Requiring Dialysis.

Asher Alban Chanan-Khan, P. Richardson, S. Lonial, D. Siegel, S. Jagannath, J. Mehta, J. Doran, S. Singhal
Journal: Blood
Blood (2005) 106 (11): 2550.
https://doi.org/10.1182/blood.V106.11.2550.2550
Published: 2005
Journal Articles

Bortezomib Demonstrates Superior Efficacy to High-Dose Dexamethasone in Relapsed Multiple Myeloma: Final Report of the APEX Study.

Paul Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. San Miguel, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2004) 104 (11): 1479.
https://doi.org/10.1182/blood.V104.11.1479.1479
Published: 2004